CAMCOLIT 400mg price in UAE

Overview

Welcome to Dwaey, specifically on CAMCOLIT 400mg Tablets page.
This medicine contains an important and useful components, as it consists of Lithium carbonate.
CAMCOLIT 400mg is available in the market in concentration 400mg/Tablet and in the form of Tablets.

NORGINE LIMITED is the producer of CAMCOLIT 400mg and it is imported from UK, The most popular alternatives of CAMCOLIT 400mg are listed downward .

Mode Of Action

Inhibits postsynaptic D2 receptor supersensitivity. Alters cation transport in nerve and muscle cells and influences reuptake of serotonin or norepinephrine. Inhibits phosphatidylinositol cycle second messenger systems.

Indication

Bipolar disorder
Mania
Recurrent unipolar depression

Precaution

Decreased tolerance to lithium has been reported to ensue from protracted sweating or diarrhoea and, if such occur, supplemental fluid and salt should be administered under careful medical supervision and lithium intake reduced or suspended until the condition is resolved. Lactation: Drug is excreted in breast milk; use not recommended

Side Effects

>10% Leukocytosis (most patients)
Polyuria/polydypsia (30-50%)
Dry mouth (20-50%)
Hand tremor (45% initially
10% after 1 year of treatment)
Confusion (40%)
Decreased memory (40%)
Headache (40%)
Muscle weakness (30% initially
1% after 1 year of treatment)
Electrocardiographic (ECG) changes (20-30%)
Nausea
vomiting
diarrhea (10-30% initially
1-10% after 1-2 years of treatment)
Hyperreflexia (15%)
Muscle twitch (15%)
Vertigo (15%) 1-10% Extrapyramidal symptoms
goiter (5%)
Hypothyroidism (1-4%)
Acne (1%)
Hair thinning (1%) Frequency Not Defined Coma
Lethargy
Seizures
Renal toxicity

Contra indication

Renal insufficiency, cardiovascular insufficiency, Addisons disease and untreated hypothyroidism are all contraindications to lithium therapy.

Pregnancy and lactation

Pregnancy category: D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Interaction

Reduced serum levels with carbonic anhydrase inhibitors, chlorpromazine, sodium-containing preparations, theophylline, urea. Enhanced hypothyroid effects with iodine salts. Enhanced effects of neuromuscular-blocking agents. Reduced pressor response to sympathomimetics. Potentially Fatal: Increased risk of lithium toxicity with ACE inhibitors, angiotensin receptor antagonists, loop diuretics, metronidazole, phenytoin. Increased risk of neurotoxicity with carbamazepine, calcium-channel blockers, haloperidol, methyldopa, phenothiazines, SSRIs, TCAs. Increased serum levels with COX-2 inhibitors, NSAIDs (except sulindac, aspirin), tetracyclines, thiazide diuretics. Increased risk of encephalopathy with haloperidol. Increased risk of serotonin syndrome with sibutramine. Fatal malignant hyperpyrexia may occur when used with MAOIs.